These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36864399)

  • 1. Integrated transcriptional analysis reveals macrophage heterogeneity and macrophage-tumor cell interactions in the progression of pancreatic ductal adenocarcinoma.
    Yang K; Yang T; Yu J; Li F; Zhao X
    BMC Cancer; 2023 Mar; 23(1):199. PubMed ID: 36864399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 3. An integrated study to decipher immunosuppressive cellular communication in the PDAC environment.
    Avşar G; Pir P
    NPJ Syst Biol Appl; 2023 Nov; 9(1):56. PubMed ID: 37945567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma.
    Lin J; Liu Y; Liu P; Qi W; Liu J; He X; Liu Q; Liu Z; Yin J; Lin J; Bao H; Lin J
    J Exp Clin Cancer Res; 2023 Dec; 42(1):339. PubMed ID: 38098044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages.
    Li MX; Wang HY; Yuan CH; Ma ZL; Jiang B; Li L; Zhang L; Xiu DR
    Clin Sci (Lond); 2021 Feb; 135(4):629-649. PubMed ID: 33538300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell mapping reveals several immune subsets associated with liver metastasis of pancreatic ductal adenocarcinoma.
    Zhang Z; Zhu XQ; Yang F; Lai NN; Zhu L; Cole K; Hu BY; Li TE; Zhu Y; Zhang LM; Wang S; Zheng Y; Mao H; Zhao Y; Bruns C; Vago R; Tu B; Wong JWH; Fu DL; Qin LX; Dong QZ
    Med; 2023 Oct; 4(10):728-743.e7. PubMed ID: 37633269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced CD10 expression during monocyte-to-macrophage differentiation identifies a unique subset of macrophages in pancreatic ductal adenocarcinoma.
    Huang X; He C; Lin G; Lu L; Xing K; Hua X; Sun S; Mao Y; Song Y; Wang J; Li S
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1064-1071. PubMed ID: 32070494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 14. The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression.
    Liu Y; Wang X; Zhu Y; Cao Y; Wang L; Li F; Zhang Y; Li Y; Zhang Z; Luo J; Deng X; Peng C; Wei G; Chen H; Shen B
    Clin Transl Med; 2022 Feb; 12(2):e654. PubMed ID: 35184402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT.
    Miraki Feriz A; Khosrojerdi A; Erfanian N; Azarkar S; Sajjadi SM; Shojaei MJ; Vaferi MJ; Safarpour H; Racanelli V
    Immunobiology; 2024 Jul; 229(4):152822. PubMed ID: 38852289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic landscape of endothelial cells: Key tumor microenvironment components indicating variable clinical outcomes in pancreatic ductal adenocarcinoma.
    Xie P; Tan SY; Li HF; Tang HD; Zhou JH
    Environ Toxicol; 2024 Feb; 39(2):572-582. PubMed ID: 37449672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.
    Zhu Y; Herndon JM; Sojka DK; Kim KW; Knolhoff BL; Zuo C; Cullinan DR; Luo J; Bearden AR; Lavine KJ; Yokoyama WM; Hawkins WG; Fields RC; Randolph GJ; DeNardo DG
    Immunity; 2017 Aug; 47(2):323-338.e6. PubMed ID: 28813661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma.
    Zhang J; Sun H; Liu S; Huang W; Gu J; Zhao Z; Qin H; Luo L; Yang J; Fang Y; Ge J; Ni B; Wang H
    Aging (Albany NY); 2020 Nov; 12(22):23217-23232. PubMed ID: 33221741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell RNA transcriptome reveals the intra-tumoral heterogeneity and regulators underlying tumor progression in metastatic pancreatic ductal adenocarcinoma.
    Xu Q; Chen S; Hu Y; Huang W
    Cell Death Discov; 2021 Nov; 7(1):331. PubMed ID: 34732701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell sequencing reveals heterogeneity between pancreatic adenosquamous carcinoma and pancreatic ductal adenocarcinoma with prognostic value.
    Zhang D; Wu S; Pan S; Wang M; Wang Z; He Z; Zhang G; Cui F; Song Y; Li W; Shi X; Huang H; Xu H
    Front Immunol; 2022; 13():972298. PubMed ID: 36052088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.